Use of dopamine antagonists in treatment of migraine

Current Treatment Options in Neurology

Volumn 14, Issue 1, 2012, Pages 27-35

  Marmura, Michael J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adverse events; Dopamine; Dopamine antagonists; Efficacy; Migraine; Nausea; Neuroleptics; Prodrome; Prophylaxis; Status migrainosus; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ARIPIPRAZOLE; ATENOLOL; ATYPICAL ANTIPSYCHOTIC AGENT; BARBITURIC ACID DERIVATIVE; CHLORPROMAZINE; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; FLUNARIZINE; HALOPERIDOL; KETOROLAC; LIDOCAINE; MAGNESIUM; METOCLOPRAMIDE; NARATRIPTAN; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PARACETAMOL; PETHIDINE; PLACEBO; PROCHLORPERAZINE; QUETIAPINE; SUMATRIPTAN; UNINDEXED DRUG; ZIPRASIDONE;

AKATHISIA; ARTICLE; BLURRED VISION; CHILL; CHRONIC DAILY HEADACHE; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG COST; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSTONIA; EVENING DOSAGE; EXTRAPYRAMIDAL SYMPTOM; GALACTORRHEA; GASTRIC DYSMOTILITY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; INFERTILITY; METABOLIC SYNDROME X; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOTOR DYSFUNCTION; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PSYCHOSIS; QT PROLONGATION; RESTLESSNESS; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; STOMACH PARESIS; TACHYCARDIA; TARDIVE DYSKINESIA; TRANSFORMED MIGRAINE; TREMOR; URINE RETENTION; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 84857639387     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-011-0150-9     Document Type: Article

References (37)

1. S Diamond ME Bigal S Silberstein E Loder M Reed RB Lipton 2001 Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study Headache 41 646 11554952 10.1046/j.1526-4610.2001.041006533.x (Pubitemid 32619253)
2. D Dodick RB Lipton V Martin V Papademetriou W Rosamond A Maassen Van Den Brink H Loutfi KM Welch PJ Goadsby S Hahn S Hutchinson D Matchar S Silberstein TR Smith RA Purdy J Saiers 2004 Triptan cardiovascular safety expert panel. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine Headache 44 5 414 25 15147249 10.1111/j.1526-4610.2004.04078.x (Pubitemid 38685549)
3. ME Bigal RB Lipton 2009 Overuse of acute migraine medications and migraine chronification Curr Pain Headache Rep 13 4 301 7 19586594 10.1007/s11916-009-0048-3 This article provides important insight into medication overuse and points to a role for neuroleptics
4. SJ Peroutka T Wilhoit K Jones 1997 Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles Neurology 49 201 6 9222191 1:CAS:528:DyaK2sXkvFems78%3D (Pubitemid 27328703)
5. F Fernandez RA Lea NJ Colson C Bellis S Quinlan LR Griffiths 2006 Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura J Neurol Sci 251 118 23 17095019 10.1016/j.jns.2006.09.013 1:CAS:528:DC%2BD28Xht1Chs73N (Pubitemid 44792154)
6. S Cevoli M Mochi C Scapoli N Marzocchi G Pierangeli LA Pini, et al. 2006 A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse Eur J Neurol 13 1009 13 16930369 10.1111/j.1468-1331. 2006.01415.x 1:STN:280:DC%2BD28rgs1OhtA%3D%3D (Pubitemid 44284910)
7. M Del Zompo M Lai V Loi MR Pisano 1995 Dopamine hypersensitivity in migraine: role in apomorphine syncope Headache 35 222 4 7775179 10.1111/j.1526-4610.1995.hed3504222.x
8. D Borsook J Upadhyay EH Chudler L Becerra 2010 A key role of the basal ganglia in pain and analgesia-insights gained through human functional imaging Mol Pain 6 27 20465845 10.1186/1744-8069-6-27 This important paper highlights changes in how we think about chronic pain
9. AS Chappell JM Bay GD Botzum ML Cohen 1994 Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine Neuropharmacology 33 3-4 509 13 7984290 10.1016/0028-3908(94)90082-5 1:CAS:528:DyaK2cXjtFGktL8%3D (Pubitemid 24168723)
10. P Damier 2009 Drug-induced dyskinesias Curr Opin Neurol 22 4 394 9 19491677 10.1097/WCO.0b013e32832d9dc4 1:CAS:528:DC%2BD1MXotFCmtrs%3D
11. J Jones D Sklar J Dougherty W White 1989 Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache JAMA 261 1174 1176 2915441 10.1001/jama.1989.03420080094038 1:STN:280:DyaL1M7isFygtg%3D%3D (Pubitemid 19062453)
12. J Jones S Pack E Chun 1996 Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache Am J Emerg Med 14 262 264 8639197 10.1016/S0735-6757(96)90171-0 1:STN:280:DyaK283ivVOqsQ%3D%3D (Pubitemid 26152101)
13. S Ginder B Oatman M Pollack 2000 A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches J Emerg Med 18 311 315 10729668 10.1016/S0736-4679(99)00220-6 1:STN:280:DC%2BD3c7psFKktQ%3D%3D (Pubitemid 30154068)
14. MB Seim JA March KA Dunn 1998 Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches Acad Emerg Med 5 573 576 9660282 10.1111/j.1553-2712.1998.tb02463.x 1:STN:280:DyaK1czitFOiuw%3D%3D (Pubitemid 28283652)
15. DC Brousseau SJ Duffy AC Anderson JG Linakis 2004 Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac Ann Emerg Med 43 2 256 62 14747817 10.1016/S0196-0644(03)00716-9 (Pubitemid 38141471)
16. GE Tietjen K Athanas C Utley NA Herial SA Khuder 2005 The combination of naratriptan and prochlorperazine in migraine treatment Headache 45 6 751 3 15953309 10.1111/j.1526-4610.2005.05143-1.x (Pubitemid 40798698)
17. V Kirthi S Derry RA Moore HJ McQuay 2010 Aspirin with or without an antiemetic for acute migraine headaches in adults Cochrane Database Syst Rev 14 1 44 This review challenges the idea that triptans should be first-line treatment for acute migraine
18. I Colman MD Brown GD Innes E Grafstein TE Roberts BH Rowe 2004 Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials BMJ 329 7479 1369 73 15550401 10.1136/bmj.38281.595718.7C 1:CAS:528:DC%2BD2MXjvFOrtQ%3D%3D (Pubitemid 39656355)
19. JA Klapper JS Stanton 1991 Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches Headache 31 523 524 1960056 10.1111/j.1526-4610.1991.hed3108523.x 1:STN:280:DyaK38%2FntFWntQ%3D%3D
20. BW Friedman L Mulvey D Esses C Solorzano J Paternoster RB Lipton EJ Gallagher 2011 Metoclopramide for acute migraine: a dose-finding randomized clinical trial Ann Emerg Med 57 5 475 482e1 21227540 10.1016/j.annemergmed.2010. 11.023 This paper reports on an excellent controlled trial in acute migraine in the emergency setting, which is relatively rare
21. ME Bigal CA Bordini JG Speciali 2002 Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial J Emerg Med 23 141 8 12359281 10.1016/S0736-4679(02)00502-4 (Pubitemid 35335337)
22. R Bell D Montoya A Shuaib MA Lee 1990 A comparative trial of three agents in the treatment of acute migraine headache Ann Emerg Med 19 1079 82 2221511 10.1016/S0196-0644(05)81507-0 1:STN:280:DyaK3M%2FitlKguw%3D%3D (Pubitemid 20365193)
23. PB Richman J Allegra B Eskin, et al. 2002 A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache Am J Emerg Med 20 39 42 11781912 10.1053/ajem.2002.30007 (Pubitemid 34052515)
24. SD Silberstein WB Young JE Mendizabal JF Rothrock AS Alam 2003 Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial Neurology 60 2 315 21 12552051 1:CAS:528: DC%2BD3sXhtVKjsQ%3D%3D (Pubitemid 36152029)
25. J Honkaniemi S Liimatainen S Rainesalo S Sulavuori 2006 Haloperidol in the acute treatment of migraine: a randomized, double-blinded, placebo-controlled study Headache 46 781 787 16643581 10.1111/j.1526-4610.2006. 00438.x
26. L Kelman 2004 The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs Headache 44 9 865 72 15447695 10.1111/j.1526-4610.2004.04168. x (Pubitemid 39362310)
27. J Waelkens 1982 Domperidone in the prevention of complete classical migraine Br Med J (Clin Res Ed) 284 6320 944 10.1136/bmj.284.6320.944 1:STN:280:DyaL387mtFyitg%3D%3D (Pubitemid 12192952)
28. J Waelkens 1984 Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study Cephalalgia 4 85 90 6375874 10.1046/j.1468-2982.1984.0402085.x 1:STN:280:DyaL2c3jtl2rtQ%3D%3D (Pubitemid 14113103)
29. TD Rozen 2004 Migraine prodrome: a nose on a face Lancet 363 517 14975613 10.1016/S0140-6736(04)15537-2 (Pubitemid 38229451)
30. LW Bisol MG Brunstein GL Ottoni FL Ramos DL Borba CS Daltio RV de Oliveira GE Paz SE de Souza RA Bressan DR Lara 2008 Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia J Clin Psychiatry 69 10 1572 9 19192440 10.4088/JCP.v69n1007 1:CAS:528:DC%2BD1cXhtlClu7jI
31. LD LaPorta 2007 Relief from migraine headache with aripiprazole treatment Headache 47 6 922 6 17578547 10.1111/j.1526-4610.2007.00777.x (Pubitemid 46944384)
32. CM Cahill O Hardiman KC Murphy 2005 Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone-a case series Cephalalgia 25 822 826 16162260 10.1111/j.1468-2982.2005.00947.x 1:STN:280: DC%2BD2MvptFKjsg%3D%3D (Pubitemid 41368678)
33. SD Silberstein MF Peres MM Hopkins, et al. 2002 Olanzapine in the treatment of refractory migraine and chronic daily headache Headache 42 515 518 12167140 10.1046/j.1526-4610.2002.02126.x (Pubitemid 37011824)
34. HC Siow WB Young SD Silberstein 2005 Neuroleptics in headache Headache 45 358 71 15836574 10.1111/j.1526-4610.2005.05074.x (Pubitemid 40530202)
35. AV Krymchantowski C Jevoux PF Moreira 2010 An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine Pain Med 11 1 48 52 20002594 10.1111/j.1526-4637.2009.00757.x This is the largest study to date of atypical neuroleptics as prophylaxis for refractory migraine
36. ED Trottier B Bailey S Dauphin-Pierre J Gravel 2010 Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department J Emerg Med 39 2 166 73 19150192 10.1016/j.jemermed.2008. 08.012
37. Trottier ED, Bailey B, Lucas N, Lortie A. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med. 2011 Feb 4. doi: 10.1016/j.ajem.2010.12.020.